Oura Health is preparing for a potential U.S. stock market debut that could raise up to $3 billion and value the smart ring maker at more than $16 billion.
The company, which makes wearable devices designed to monitor sleep, fitness and other health metrics, could launch its IPO as early as next month, sources familiar with the plans told Bloomberg. The offering is also expected to include a substantial secondary component, allowing some of Oura’s existing investors to cash out part of their stakes in the company.
Details surrounding the IPO are still in the works and subject to change.
The company filed confidentialy for its IPO in May, and has retained Goldman Sachs, Morgan Stanley, JPMorgan Chase, Allen & Co. and Jefferies Financial Group to work on the public offering.
The San Francisco and Finland-based company was founded in 2013 by Petteri Lahtela, Kari Kivela, and Markku Koskela. In September 2025, the company’s valuation hit $11 billion, after a funding round raised $875 million in Series E.
